News
Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...
1d
First Alert 4 on MSNProviders, patients speak out after First Alert 4 Investigation uncovers IV safety concerns at some BJC facilitiesCare providers and patients are now speaking out after a First Alert 4 investigation Monday revealed safety concerns with IV ...
Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results